Cape Investment Advisory’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-111
Closed -$796 878
2025
Q4
$796 Buy
111
+67
+152% +$529 ﹤0.01% 1215
2025
Q3
$470 Sell
44
-86
-66% -$844 ﹤0.01% 782
2025
Q2
$1.26K Hold
130
﹤0.01% 1008
2025
Q1
$1.94K Hold
130
﹤0.01% 896
2024
Q4
$1.94K Buy
130
+44
+51% +$717 ﹤0.01% 883
2024
Q3
$1.64K Hold
86
﹤0.01% 845
2024
Q2
$1.78K Hold
86
﹤0.01% 796
2024
Q1
$1.61K Sell
86
-70
-45% -$1.2K ﹤0.01% 791
2023
Q4
$2.25K Buy
156
+7
+5% +$95 ﹤0.01% 909
2023
Q3
$2.58K Sell
149
-33
-18% -$688 ﹤0.01% 768
2023
Q2
$3.78K Sell
182
-29
-14% -$630 ﹤0.01% 701
2023
Q1
$4.96K Buy
+211
New +$5.67K ﹤0.01% 676

Other funds holding OGN

Cape Investment Advisory's OGN Position: Q1 2026 in Review

Cape Investment Advisory sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 111 shares — an estimated $796 sold.

Cape Investment Advisory first reported a position in OGN in Q1 2023 and held it in 12 quarters. The position peaked at $4.96K in Q1 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Cape Investment Advisory reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Cape Investment Advisory sold 111 Organon & Co shares in Q1 2026, an estimated $796.
  • Cape Investment Advisory first reported a position in Organon & Co in Q1 2023 and held it in 12 quarters.
  • Cape Investment Advisory's Organon & Co position peaked at $4.96K in Q1 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Cape Investment Advisory's 13F filing for Q1 2026, filed 15 May 2026.